Norvasc Patent Still Invalid: Court
An appeals court refused Monday to rehear Pfizer Inc.'s case against Apotex Inc., giving the Canadian generics-maker the green light to launch a generic form of Pfizer's blockbuster blood-pressure drug Norvasc....To view the full article, register now.
Already a subscriber? Click here to view full article